Learn about C. difficile Infection (CDI) diagnosis, including clinical documentation and medical coding for Clostridioides difficile. Find information on C. diff testing, treatment, and management. This resource provides healthcare professionals with key insights into CDI for accurate and efficient clinical documentation and coding.
Also known as
Enterocolitis due to Clostridium difficile
Infection of the large intestine caused by C. difficile bacteria.
Other bacterial intestinal infections
Bacterial infections affecting the intestines, excluding common types like Salmonella.
Intestinal infectious diseases
Diseases of the intestines caused by various infectious agents.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the C. difficile infection confirmed?
When to use each related code
| Description |
|---|
| Infection causing diarrhea and colitis. |
| Antibiotic-associated diarrhea not due to C. diff. |
| Inflammation of the colon from various causes. |
Coding C. difficile without specifying if it's initial or recurrent episode leads to inaccurate severity and quality reporting. Use appropriate ICD-10 codes (A04.71, A04.72).
Failing to document CDI as present on admission (POA) impacts hospital-acquired infection reporting and reimbursement. Accurate POA indicator is crucial for compliance.
Coding CDI without proper clinical documentation like positive lab tests or imaging studies supporting the diagnosis can trigger claim denials and audits. Ensure complete medical record.
Q: What are the latest evidence-based treatment guidelines for recurrent Clostridioides difficile infection (CDI) in adults?
A: Recurrent Clostridioides difficile infection (CDI) poses a significant clinical challenge. Current evidence-based guidelines from organizations like the IDSA and SHEA recommend a tiered approach to treatment based on recurrence number and severity. For a first recurrence, fidaxomicin or a pulsed-tapered vancomycin regimen is recommended. For second or further recurrences, bezlotoxumab is an option for preventing further recurrence, especially in high-risk individuals. Fecal microbiota transplantation (FMT) is now considered a first-line therapy for recurrent CDI and has demonstrated high efficacy rates. Explore how FMT is changing the landscape of recurrent CDI treatment and consider implementing these updated guidelines in your practice. For patients with severe or fulminant CDI, surgery may be necessary. Learn more about the role of surgery in managing complicated CDI.
Q: How can I differentiate Clostridioides difficile (C. diff) infection from other causes of antibiotic-associated diarrhea in my patients?
A: Differentiating Clostridioides difficile (C. diff) infection from other causes of antibiotic-associated diarrhea requires a comprehensive approach. While antibiotic-associated diarrhea can be caused by various factors, including disrupted gut microbiota, C. diff infection presents with distinct clinical features. Consider the patient's antibiotic exposure, the onset and duration of diarrhea, and the presence of other symptoms such as abdominal pain, fever, or leukocytosis. Laboratory testing, specifically stool testing for C. difficile toxins (using either a nucleic acid amplification test or glutamate dehydrogenase followed by toxin testing), is crucial for confirming the diagnosis. Explore the latest diagnostic algorithms for C. diff infection, including the importance of toxin testing and the limitations of PCR alone. Consider implementing a standardized diagnostic pathway for antibiotic-associated diarrhea to accurately identify and manage C. diff infections in your practice.
Patient presents with complaints consistent with Clostridioides difficile infection (CDI, C. diff), including frequent watery diarrhea, abdominal pain, and cramping. Onset of symptoms began approximately [Number] days ago following recent antibiotic therapy with [Antibiotic Name and Dosage]. Patient reports [Number] bowel movements per day with stool characterized as loose and watery, sometimes containing mucus. Patient denies blood in stool. Abdominal examination reveals mild tenderness to palpation in the [Location] quadrant. The patient exhibits signs of dehydration including dry mucous membranes and decreased skin turgor. Vital signs show a temperature of [Temperature], heart rate of [Heart Rate], blood pressure of [Blood Pressure], and respiratory rate of [Respiratory Rate]. Laboratory tests ordered include a C. difficile toxin assay and complete blood count (CBC) to assess for leukocytosis. Given the patient's clinical presentation and recent antibiotic use, the presumptive diagnosis is C. difficile colitis. Treatment initiated with oral [Medication Name and Dosage]. Patient education provided regarding infection control precautions, including hand hygiene and environmental disinfection. Plan to monitor patient's clinical response to therapy and adjust treatment as needed. Differential diagnoses considered include antibiotic-associated diarrhea, inflammatory bowel disease, and irritable bowel syndrome. ICD-10 code A04.7 assigned. Follow-up scheduled in [Number] days to reassess symptoms and treatment efficacy.